Filing Details
- Accession Number:
- 0001209191-10-029450
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-20 13:00:00
- Reporting Period:
- 2010-05-18
- Filing Date:
- 2010-05-20
- Accepted Time:
- 2010-05-20 18:41:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1238250 | A Michael Martino | 1522 217Th Pl Se, Suite 100 Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-18 | 1,500 | $6.66 | 12,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-05-18 | 1,500 | $18.18 | 11,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | stock option (right to buy) | Disposition | 2010-05-18 | 1,500 | $0.00 | 1,500 | $6.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,017 | 2008-03-18 | 2018-03-18 | No | 4 | M | Direct |
Footnotes
- This is the weighted average price. The prices ranged from $18.06 to $18.75. The reporting person undertakes to provide on request a detailed breakout of the pricing.